Psychotic Disorders  >>  galantamine hydrobromide  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
galantamine hydrobromide / Generic mfg.
NCT00297362: A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Completed
N/A
344
Europe
Galantamine hydrobromide
Janssen Cilag Pharmaceutica S.A.C.I., Greece
Alzheimer Disease
 
10/05
NCT00181636: Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder

Completed
N/A
25
US
Galantamine-CR
Massachusetts General Hospital
Bipolar Disorder
 
10/06

Download Options